molecular function |
| GO:0008083 | | growth factor activity | | The function that stimulates a cell to grow or proliferate. Most growth factors have other actions besides the induction of cell growth or proliferation. |
| GO:0005179 | | hormone activity | | The action characteristic of a hormone, any substance formed in very small amounts in one specialized organ or group of cells and carried (sometimes in the bloodstream) to another organ or group of cells in the same organism, upon which it has a specific regulatory action. The term was originally applied to agents with a stimulatory physiological action in vertebrate animals (as opposed to a chalone, which has a depressant action). Usage is now extended to regulatory compounds in lower animals and plants, and to synthetic substances having comparable effects; all bind receptors and trigger some biological process. |
| GO:0005158 | | insulin receptor binding | | Interacting selectively and non-covalently with the insulin receptor. |
| GO:0005159 | | insulin-like growth factor receptor binding | | Interacting selectively and non-covalently with the insulin-like growth factor receptor. |
| GO:0005178 | | integrin binding | | Interacting selectively and non-covalently with an integrin. |
| GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| GO:0005496 | | steroid binding | | Interacting selectively and non-covalently with a steroid, any of a large group of substances that have in common a ring system based on 1,2-cyclopentanoperhydrophenanthrene. |
biological process |
| GO:0006260 | | DNA replication | | The cellular metabolic process in which a cell duplicates one or more molecules of DNA. DNA replication begins when specific sequences, known as origins of replication, are recognized and bound by initiation proteins, and ends when the original DNA molecule has been completely duplicated and the copies topologically separated. The unit of replication usually corresponds to the genome of the cell, an organelle, or a virus. The template for replication can either be an existing DNA molecule or RNA. |
| GO:0070371 | | ERK1 and ERK2 cascade | | An intracellular protein kinase cascade containing at least ERK1 or ERK2 (MAPKs), a MEK (a MAPKK) and a MAP3K. The cascade can also contain two additional tiers: the upstream MAP4K and the downstream MAP Kinase-activated kinase (MAPKAPK). The kinases in each tier phosphorylate and activate the kinases in the downstream tier to transmit a signal within a cell. |
| GO:0007265 | | Ras protein signal transduction | | A series of molecular signals within the cell that are mediated by a member of the Ras superfamily of proteins switching to a GTP-bound active state. |
| GO:0000187 | | activation of MAPK activity | | The initiation of the activity of the inactive enzyme MAP kinase (MAPK). |
| GO:0032148 | | activation of protein kinase B activity | | Any process that initiates the activity of the inactive enzyme protein kinase B. |
| GO:0007568 | | aging | | A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700). |
| GO:0035630 | | bone mineralization involved in bone maturation | | The deposition of hydroxyapatite, involved in the progression of the skeleton from its formation to its mature state. |
| GO:0001775 | | cell activation | | A change in the morphology or behavior of a cell resulting from exposure to an activating factor such as a cellular or soluble ligand. |
| GO:0008283 | | cell proliferation | | The multiplication or reproduction of cells, resulting in the expansion of a cell population. |
| GO:0044267 | | cellular protein metabolic process | | The chemical reactions and pathways involving a specific protein, rather than of proteins in general, occurring at the level of an individual cell. Includes cellular protein modification. |
| GO:0071257 | | cellular response to electrical stimulus | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an electrical stimulus. |
| GO:0071392 | | cellular response to estradiol stimulus | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen. |
| GO:0032869 | | cellular response to insulin stimulus | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin stimulus. Insulin is a polypeptide hormone produced by the islets of Langerhans of the pancreas in mammals, and by the homologous organs of other organisms. |
| GO:0050974 | | detection of mechanical stimulus involved in sensory perception | | The series of events in which a mechanical stimulus is received and converted into a molecular signal as part of sensory perception. |
| GO:0007565 | | female pregnancy | | The set of physiological processes that allow an embryo or foetus to develop within the body of a female animal. It covers the time from fertilization of a female ovum by a male spermatozoon until birth. |
| GO:0009441 | | glycolate metabolic process | | The chemical reactions and pathways involving glycolate, the anion of hydroxyethanoic acid (glycolic acid). |
| GO:0048009 | | insulin-like growth factor receptor signaling pathway | | The series of molecular signals generated as a consequence of the insulin-like growth factor receptor binding to one of its physiological ligands. |
| GO:0007613 | | memory | | The activities involved in the mental information processing system that receives (registers), modifies, stores, and retrieves informational stimuli. The main stages involved in the formation and retrieval of memory are encoding (processing of received information by acquisition), storage (building a permanent record of received information as a result of consolidation) and retrieval (calling back the stored information and use it in a suitable way to execute a given task). |
| GO:0006928 | | movement of cell or subcellular component | | The directed, self-propelled movement of a cell or subcellular component without the involvement of an external agent such as a transporter or a pore. |
| GO:0014896 | | muscle hypertrophy | | The muscle system process that results in enlargement or overgrowth of all or part of a muscle organ due to an increase in the size of its muscle cells. Physiological hypertrophy is a normal process during development (it stops in cardiac muscle after adolescence) and can also be brought on in response to demand. In athletes cardiac and skeletal muscles undergo hypertrophy stimulated by increasing muscle activity on exercise. Smooth muscle cells in the uterus undergo hypertrophy during pregnancy. |
| GO:0007517 | | muscle organ development | | The process whose specific outcome is the progression of the muscle over time, from its formation to the mature structure. The muscle is an organ consisting of a tissue made up of various elongated cells that are specialized to contract and thus to produce movement and mechanical work. |
| GO:0045445 | | myoblast differentiation | | The process in which a relatively unspecialized cell acquires specialized features of a myoblast. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into striated muscle fibers. |
| GO:0051450 | | myoblast proliferation | | The multiplication or reproduction of myoblasts, resulting in the expansion of a myoblast cell population. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into skeletal muscle fibers. |
| GO:0014904 | | myotube cell development | | The process aimed at the progression of a myotube cell over time, from initial commitment of the cell to a specific fate, to the fully functional differentiated cell. Myotubes are multinucleated cells that are formed when proliferating myoblasts exit the cell cycle, differentiate and fuse. |
| GO:0043066 | | negative regulation of apoptotic process | | Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process. |
| GO:1904193 | | negative regulation of cholangiocyte apoptotic process | | Any process that stops, prevents or reduces the frequency, rate or extent of cholangiocyte apoptotic process. |
| GO:2001237 | | negative regulation of extrinsic apoptotic signaling pathway | | Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway. |
| GO:1901215 | | negative regulation of neuron death | | Any process that stops, prevents or reduces the frequency, rate or extent of neuron death. |
| GO:0060283 | | negative regulation of oocyte development | | Any process that decreases the rate or extent of the process whose specific outcome is the progression of an oocyte over time, from initial commitment of the cell to its specific fate, to the fully functional differentiated cell. |
| GO:0090201 | | negative regulation of release of cytochrome c from mitochondria | | Any process that decreases the rate, frequency or extent of release of cytochrome c from mitochondria, the process in which cytochrome c is enabled to move from the mitochondrial intermembrane space into the cytosol, which is an early step in apoptosis and leads to caspase activation. |
| GO:0034392 | | negative regulation of smooth muscle cell apoptotic process | | Any process that stops, prevents, or reduces the frequency, rate, or extent of smooth muscle cell apoptotic process. |
| GO:0014065 | | phosphatidylinositol 3-kinase signaling | | A series of reactions within the signal-receiving cell, mediated by the intracellular phosphatidylinositol 3-kinase (PI3K). Many cell surface receptor linked signaling pathways signal through PI3K to regulate numerous cellular functions. |
| GO:0048015 | | phosphatidylinositol-mediated signaling | | A series of molecular signals in which a cell uses a phosphatidylinositol-mediated signaling to convert a signal into a response. Phosphatidylinositols include phosphatidylinositol (PtdIns) and its phosphorylated derivatives. |
| GO:0002576 | | platelet degranulation | | The regulated exocytosis of secretory granules containing preformed mediators such as histamine and serotonin by a platelet. |
| GO:0043388 | | positive regulation of DNA binding | | Any process that increases the frequency, rate or extent of DNA binding. DNA binding is any process in which a gene product interacts selectively with DNA (deoxyribonucleic acid). |
| GO:0045740 | | positive regulation of DNA replication | | Any process that activates or increases the frequency, rate or extent of DNA replication. |
| GO:0043410 | | positive regulation of MAPK cascade | | Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the MAPK cascade. |
| GO:0046579 | | positive regulation of Ras protein signal transduction | | Any process that activates or increases the frequency, rate or extent of Ras protein signal transduction. |
| GO:0042104 | | positive regulation of activated T cell proliferation | | Any process that activates or increases the rate or extent of activated T cell proliferation. |
| GO:0070886 | | positive regulation of calcineurin-NFAT signaling cascade | | Any process that activates or increases the frequency, rate or extent of signaling via the calcineurin-NFAT signaling cascade. |
| GO:0010613 | | positive regulation of cardiac muscle hypertrophy | | Any process that increases the rate, frequency or extent of the enlargement or overgrowth of all or part of the heart due to an increase in size (not length) of individual cardiac muscle fibers, without cell division. |
| GO:0030307 | | positive regulation of cell growth | | Any process that activates or increases the frequency, rate, extent or direction of cell growth. |
| GO:0030335 | | positive regulation of cell migration | | Any process that activates or increases the frequency, rate or extent of cell migration. |
| GO:0008284 | | positive regulation of cell proliferation | | Any process that activates or increases the rate or extent of cell proliferation. |
| GO:0050679 | | positive regulation of epithelial cell proliferation | | Any process that activates or increases the rate or extent of epithelial cell proliferation. |
| GO:0045600 | | positive regulation of fat cell differentiation | | Any process that activates or increases the frequency, rate or extent of adipocyte differentiation. |
| GO:0048146 | | positive regulation of fibroblast proliferation | | Any process that activates or increases the frequency, rate or extent of multiplication or reproduction of fibroblast cells. |
| GO:0046326 | | positive regulation of glucose import | | Any process that activates or increases the frequency, rate or extent of the import of the hexose monosaccharide glucose into a cell or organelle. |
| GO:0045725 | | positive regulation of glycogen biosynthetic process | | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of glycogen. |
| GO:0045821 | | positive regulation of glycolytic process | | Any process that activates or increases the frequency, rate or extent of glycolysis. |
| GO:0010560 | | positive regulation of glycoprotein biosynthetic process | | Any process that increases the rate, frequency, or extent of the chemical reactions and pathways resulting in the formation of glycoproteins, any protein that contains covalently bound glycose (i.e. monosaccharide) residues; the glycose occurs most commonly as oligosaccharide or fairly small polysaccharide but occasionally as monosaccharide. |
| GO:0043568 | | positive regulation of insulin-like growth factor receptor signaling pathway | | Any process that increases the frequency, rate or extent of insulin-like growth factor receptor signaling. |
| GO:0045840 | | positive regulation of mitotic nuclear division | | Any process that activates or increases the frequency, rate or extent of mitosis. |
| GO:0045669 | | positive regulation of osteoblast differentiation | | Any process that activates or increases the frequency, rate or extent of osteoblast differentiation. |
| GO:0050731 | | positive regulation of peptidyl-tyrosine phosphorylation | | Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine. |
| GO:0014068 | | positive regulation of phosphatidylinositol 3-kinase signaling | | Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade. |
| GO:0033160 | | positive regulation of protein import into nucleus, translocation | | Any process that activates or increases the vectorial transfer of a protein from the cytoplasm into the nucleus, across the nuclear membrane. |
| GO:0050714 | | positive regulation of protein secretion | | Any process that activates or increases the frequency, rate or extent of the controlled release of a protein from a cell. |
| GO:0014911 | | positive regulation of smooth muscle cell migration | | Any process that activates, maintains or increases the frequency, rate or extent of smooth muscle cell migration. |
| GO:0048661 | | positive regulation of smooth muscle cell proliferation | | Any process that activates or increases the rate or extent of smooth muscle cell proliferation. |
| GO:0045944 | | positive regulation of transcription from RNA polymerase II promoter | | Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
| GO:2000679 | | positive regulation of transcription regulatory region DNA binding | | Any process that activates or increases the frequency, rate or extent of transcription regulatory region DNA binding. |
| GO:0045893 | | positive regulation of transcription, DNA-templated | | Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription. |
| GO:1904075 | | positive regulation of trophectodermal cell proliferation | | Any process that activates or increases the frequency, rate or extent of trophectodermal cell proliferation. |
| GO:0043491 | | protein kinase B signaling | | A series of reactions, mediated by the intracellular serine/threonine kinase protein kinase B (also called AKT), which occurs as a result of a single trigger reaction or compound. |
| GO:0050821 | | protein stabilization | | Any process involved in maintaining the structure and integrity of a protein and preventing it from degradation or aggregation. |
| GO:0030166 | | proteoglycan biosynthetic process | | The chemical reactions and pathways resulting in the formation of proteoglycans, any glycoprotein in which the carbohydrate units are glycosaminoglycans. |
| GO:0051924 | | regulation of calcium ion transport | | Any process that modulates the frequency, rate or extent of the directed movement of calcium ions into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
| GO:0042127 | | regulation of cell proliferation | | Any process that modulates the frequency, rate or extent of cell proliferation. |
| GO:0010468 | | regulation of gene expression | | Any process that modulates the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form. |
| GO:0040014 | | regulation of multicellular organism growth | | Any process that modulates the frequency, rate or extent of growth of the body of an organism so that it reaches its usual body size. |
| GO:0006417 | | regulation of translation | | Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of proteins by the translation of mRNA or circRNA. |
| GO:0014823 | | response to activity | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an activity stimulus. |
| GO:0031000 | | response to caffeine | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a caffeine stimulus. Caffeine is an alkaloid found in numerous plant species, where it acts as a natural pesticide that paralyzes and kills certain insects feeding upon them. |
| GO:0051384 | | response to glucocorticoid | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucocorticoid stimulus. Glucocorticoids are hormonal C21 corticosteroids synthesized from cholesterol with the ability to bind with the cortisol receptor and trigger similar effects. Glucocorticoids act primarily on carbohydrate and protein metabolism, and have anti-inflammatory effects. |
| GO:0009408 | | response to heat | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a heat stimulus, a temperature stimulus above the optimal temperature for that organism. |
| GO:0001666 | | response to hypoxia | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level. |
| GO:0032496 | | response to lipopolysaccharide | | Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria. |
| GO:0009612 | | response to mechanical stimulus | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus. |
| GO:0035094 | | response to nicotine | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nicotine stimulus. |
| GO:0007584 | | response to nutrient | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nutrient stimulus. |
| GO:0031667 | | response to nutrient levels | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus reflecting the presence, absence, or concentration of nutrients. |
| GO:0014070 | | response to organic cyclic compound | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus. |
| GO:0010033 | | response to organic substance | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic substance stimulus. |
| GO:0048545 | | response to steroid hormone | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a steroid hormone stimulus. |
| GO:0007165 | | signal transduction | | The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell. |
| GO:0014834 | | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration | | Any process by which the number of skeletal muscle satellite cells in a skeletal muscle is maintained during muscle regeneration. There are at least three mechanisms by which this is achieved. Skeletal muscle satellite stem cell asymmetric division ensures satellite stem cell numbers are kept constant. Symmetric division of these cells amplifies the number of skeletal muscle satellite stem cells. Some adult skeletal muscle myoblasts (descendants of activated satellite cells) can develop back into quiescent satellite cells, replenishing the overall pool of satellite cells. |
| GO:0001501 | | skeletal system development | | The process whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure. The skeleton is the bony framework of the body in vertebrates (endoskeleton) or the hard outer envelope of insects (exoskeleton or dermoskeleton). |
cellular component |
| GO:0035867 | | alphav-beta3 integrin-IGF-1-IGF1R complex | | A protein complex that consists of an alphav-beta3 integrin complex bound to insulin-like growth factor-1 (IGF-1) and type I insulin-like growth factor receptor (IGF1R). IGF1R is a heterotetramer that consists of two alpha-subunits and two beta-subunits. |
| GO:0005737 | | cytoplasm | | All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| GO:0070382 | | exocytic vesicle | | A transport vesicle that mediates transport from an intracellular compartment to the plasma membrane, and fuses with the plasma membrane to release various cargo molecules, such as proteins or hormones, by exocytosis. |
| GO:0005576 | | extracellular region | | The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. |
| GO:0005615 | | extracellular space | | That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
| GO:0016942 | | insulin-like growth factor binding protein complex | | A complex of proteins which includes the insulin-like growth factor (IGF) and a number of IGF-binding proteins. The complex plays a role in growth and development. |
| GO:0042567 | | insulin-like growth factor ternary complex | | A complex of three proteins, which in animals is approximately 150kDa and consists of the insulin-like growth factor (IGF), the insulin-like growth factor binding protein-3 (IGFBP-3), or -5 (IGFBP-5) and an acid-labile subunit (ALS). The complex plays a role in growth and development. |
| GO:0005614 | | interstitial matrix | | A type of extracellular matrix found in interstitial connective tissue, characterized by the presence of fibronectins, proteoglycans, and types I, III, V, VI, VII and XII collagens. |
| GO:0043025 | | neuronal cell body | | The portion of a neuron that includes the nucleus, but excludes cell projections such as axons and dendrites. |
| GO:0005886 | | plasma membrane | | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
| GO:0031093 | | platelet alpha granule lumen | | The volume enclosed by the membrane of the platelet alpha granule. |